Levomethorphan
| LVM | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 271.40 g/mol [1] |
| Solubility | 8.51 mg/L [1] |
| Predicted LogP | 3.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H25NO |
| IUPAC name | (1R,9R,10R)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene |
| SMILES | CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)OC |
| InChI | InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m0/s1 |
| InChIKey | MKXZASYAUGDDCJ-CGTJXYLNSA-N |
| CAS number | 125-70-2 |
| UNII | 8YB8F78WM1 |
| PubChem CID | 5362449 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3-6 hours |
| Dependence liability | High |
| Addiction liability | High |
Levomethorphan (also known as l-Methorphan, Levomethorphane, Levometorfano, Levomethorphanum, (-)-3-Methoxy-N-methylmorphinan, Ids-nl-004, Ids-nl-005, 204-751-7, Methorphan or 3-Methoxy-17-methylmorphinan) is a opioid substance of the 2-benzylpiperidine and morphinan class.
Chemistry
Stereochemistry []
Levomethorphan is a single defined stereoisomer (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Levomethorphan matches Lipinski's rule of five.Pharmacology
MeSH Classification
Interactions []
Subjective effects []
Legal status []
- Australia: Levomethorphan is a Schedule 9.
- Brazil: Levomethorphan is a A1.[3]
- Canada: Levomethorphan is a Schedule I.
- United States: Levomethorphan is a Schedule II under the "Controlled Substances Act".
- United Kingdom: Levomethorphan is a Class A under the "Misuse of Drugs Act 1971".
- Germany: Levomethorphan is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5362449, Levomethorphan. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5362449
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Levomethorphan. UNII: 8YB8F78WM1. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8YB8F78WM1
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 16:01:34 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 16:01:30 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 16:01:30 |
| gsrs | ok | 2026-11-20 16:01:30 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0001920) | 2026-11-20 16:01:30 |
| kegg | ok | 2026-11-20 16:01:32 |
| pubchem | ok | 2026-11-20 16:01:30 |
| missing (no r/tripreports posts mention it) | 2026-11-20 16:01:30 | |
| sider | missing (not in SIDER) | 2026-11-20 16:01:30 |
| structure | ok | 2026-11-20 16:01:30 |
| wikipedia | ok | 2026-11-20 16:01:30 |